Researchers at the Medical and Surgical Center for Retina have developed software that detects eye diseases such as diabetic macular edema using a smartphone. The system is aimed at general physicians who could detect the ...
Jul 6, 2015
0
35
A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those receiving Avastin (bevacizumab), ...
Feb 28, 2016
0
46
Indigenous people in Australia experience three times more vision loss than non-Indigenous people, creating a concerning gap for vision.
Apr 19, 2022
0
2
(HealthDay)—Diet soda consumption may up the odds of diabetic retinopathy (DR), according to a study published online Jan. 23 in Clinical & Experimental Ophthalmology.
Jan 30, 2018
0
25
(HealthDay)—Implementation of non-mydriatic ultrawide field retinal imaging (UWFI) in a telemedicine program significantly reduces the ungradable rate in evaluation of patients for diabetic retinopathy (DR) and diabetic ...
Aug 21, 2013
0
0
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug ...
Sep 24, 2021
0
11
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...
Aug 13, 2012
0
0
A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show. ...
Oct 22, 2020
0
1
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published online by JAMA Ophthalmology.
Mar 16, 2017
0
18
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National ...
May 9, 2017
0
0
